- call +1-201-465-4211
- email sales@mrinsights.biz
The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine’s fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.
Scope of the Report:
This report studies the Canine Arthritis Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Canine Arthritis Treatment market by product type and applications/end industries.
The global Canine Arthritis Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Canine Arthritis Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Elanco (Eli Lilly and Company)
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Bayer AG
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Stem Cell Therapy
Market Segment by Applications, can be divided into
Veterinary Hospitals and Clinics
Retail Pharmacies
Drug Stores
E-commerce
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Canine Arthritis Treatment Market Overview
1.1 Product Overview and Scope of Canine Arthritis Treatment
1.2 Classification of Canine Arthritis Treatment by Types
1.2.1 Global Canine Arthritis Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Canine Arthritis Treatment Revenue Market Share by Types in 2017
1.2.3 Non-Steroidal Anti-Inflammatory Drugs
1.2.4 Opioids
1.2.5 Stem Cell Therapy
1.3 Global Canine Arthritis Treatment Market by Application
1.3.1 Global Canine Arthritis Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Veterinary Hospitals and Clinics
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 E-commerce
1.4 Global Canine Arthritis Treatment Market by Regions
1.4.1 Global Canine Arthritis Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Canine Arthritis Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Canine Arthritis Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Canine Arthritis Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Canine Arthritis Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Canine Arthritis Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Canine Arthritis Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Elanco (Eli Lilly and Company)
2.1.1 Business Overview
2.1.2 Canine Arthritis Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boehringer Ingelheim
2.2.1 Business Overview
2.2.2 Canine Arthritis Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boehringer Ingelheim Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Zoetis Inc
2.3.1 Business Overview
2.3.2 Canine Arthritis Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Zoetis Inc Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Vetoquinol S.A.
2.4.1 Business Overview
2.4.2 Canine Arthritis Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Vetoquinol S.A. Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bayer AG
2.5.1 Business Overview
2.5.2 Canine Arthritis Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bayer AG Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Aratana Therapeutics Inc
2.6.1 Business Overview
2.6.2 Canine Arthritis Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Norbrook Laboratories Limited
2.7.1 Business Overview
2.7.2 Canine Arthritis Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 VetStem Biopharma
2.8.1 Business Overview
2.8.2 Canine Arthritis Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 VetStem Biopharma Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Dechra Pharmaceuticals Plc
2.9.1 Business Overview
2.9.2 Canine Arthritis Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Canine Arthritis Treatment Market Competition, by Players
3.1 Global Canine Arthritis Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Canine Arthritis Treatment Players Market Share
3.2.2 Top 10 Canine Arthritis Treatment Players Market Share
3.3 Market Competition Trend
4 Global Canine Arthritis Treatment Market Size by Regions
4.1 Global Canine Arthritis Treatment Revenue and Market Share by Regions
4.2 North America Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
5 North America Canine Arthritis Treatment Revenue by Countries
5.1 North America Canine Arthritis Treatment Revenue by Countries (2013-2018)
5.2 USA Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
6 Europe Canine Arthritis Treatment Revenue by Countries
6.1 Europe Canine Arthritis Treatment Revenue by Countries (2013-2018)
6.2 Germany Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
6.4 France Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Canine Arthritis Treatment Revenue by Countries
7.1 Asia-Pacific Canine Arthritis Treatment Revenue by Countries (2013-2018)
7.2 China Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
7.5 India Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
8 South America Canine Arthritis Treatment Revenue by Countries
8.1 South America Canine Arthritis Treatment Revenue by Countries (2013-2018)
8.2 Brazil Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Canine Arthritis Treatment by Countries
9.1 Middle East and Africa Canine Arthritis Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Canine Arthritis Treatment Revenue and Growth Rate (2013-2018)
10 Global Canine Arthritis Treatment Market Segment by Type
10.1 Global Canine Arthritis Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Canine Arthritis Treatment Market Forecast by Type (2018-2023)
10.3 Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2013-2023)
10.4 Opioids Revenue Growth Rate (2013-2023)
10.5 Stem Cell Therapy Revenue Growth Rate (2013-2023)
11 Global Canine Arthritis Treatment Market Segment by Application
11.1 Global Canine Arthritis Treatment Revenue Market Share by Application (2013-2018)
11.2 Canine Arthritis Treatment Market Forecast by Application (2018-2023)
11.3 Veterinary Hospitals and Clinics Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Drug Stores Revenue Growth (2013-2018)
11.6 E-commerce Revenue Growth (2013-2018)
12 Global Canine Arthritis Treatment Market Size Forecast (2018-2023)
12.1 Global Canine Arthritis Treatment Market Size Forecast (2018-2023)
12.2 Global Canine Arthritis Treatment Market Forecast by Regions (2018-2023)
12.3 North America Canine Arthritis Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Canine Arthritis Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Canine Arthritis Treatment Revenue Market Forecast (2018-2023)
12.6 South America Canine Arthritis Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Canine Arthritis Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Canine Arthritis Treatment Picture
Table Product Specifications of Canine Arthritis Treatment
Table Global Canine Arthritis Treatment and Revenue (Million USD) Marke
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
